|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.890 USD | -6.32% |
|
-1.01% | -23.11% |
| 11/03 | Niagen Bioscience, Inc. Launches Niagen Skincare Innovation Lab and Debuts Niagen Nanocloud | CI |
| 05/03 | Top Premarket Gainers | MT |
| Capitalization | 392M 339M 306M 293M 534M 36.19B 549M 3.62B 1.44B 17.3B 1.47B 1.44B 62.32B | P/E ratio 2026 * |
18.1x | P/E ratio 2027 * | 14.2x |
|---|---|---|---|---|---|
| Enterprise value | 392M 339M 306M 293M 534M 36.19B 549M 3.62B 1.44B 17.3B 1.47B 1.44B 62.32B | EV / Sales 2026 * |
2.65x | EV / Sales 2027 * | 2.28x |
| Free-Float |
64.6% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Niagen Bioscience, Inc.
| 1 day | -6.32% | ||
| 1 week | -1.01% | ||
| Current month | -3.17% | ||
| 1 month | -4.31% | ||
| 3 months | -26.24% | ||
| 6 months | -49.17% | ||
| Current year | -23.11% |
| 1 week | 4.82 | 5.4 | |
| 1 month | 4.72 | 5.78 | |
| Current year | 4.72 | 6.86 | |
| 1 year | 4.72 | 14.69 | |
| 3 years | 1.25 | 14.69 | |
| 5 years | 1.15 | 14.69 | |
| 10 years | 1.15 | 23.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Fried
CEO | Chief Executive Officer | 66 | 01/06/2018 |
Ozan Pamir
DFI | Director of Finance/CFO | 35 | 21/10/2024 |
Aron Erickson
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Jaksch
CHM | Chairman | 57 | 22/06/2018 |
Robert Fried
BRD | Director/Board Member | 66 | 09/07/2015 |
Steven Rubin
BRD | Director/Board Member | 65 | 27/03/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -6.32% | -1.01% | -38.10% | +230.41% | 392M | ||
| -1.39% | -6.85% | -8.31% | -8.31% | 44.08B | ||
| -2.12% | -0.04% | +21.65% | +38.23% | 33.16B | ||
| +1.46% | +5.88% | +18.52% | +47.53% | 30.96B | ||
| +0.38% | -3.54% | -6.49% | -13.02% | 28.8B | ||
| +0.74% | -1.58% | +156.08% | +379.72% | 19.74B | ||
| -5.41% | -5.75% | +56.22% | +114.20% | 13.96B | ||
| +2.34% | +2.55% | +46.60% | +172.31% | 13.56B | ||
| -0.75% | -5.48% | +25.26% | -0.38% | 12.88B | ||
| -1.15% | -5.87% | +126.43% | +120.23% | 12.35B | ||
| Average | -1.22% | -2.88% | +39.79% | +108.09% | 20.99B | |
| Weighted average by Cap. | -0.62% | -3.15% | +33.86% | +71.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 148M 128M 115M 110M 201M 13.64B 207M 1.36B 544M 6.52B 555M 543M 23.49B | 172M 148M 134M 128M 234M 15.84B 240M 1.58B 631M 7.57B 644M 631M 27.28B |
| Net income | 22.46M 19.41M 17.52M 16.76M 30.55M 2.07B 31.41M 207M 82.57M 990M 84.29M 82.51M 3.57B | 28.48M 24.61M 22.22M 21.25M 38.73M 2.63B 39.82M 263M 105M 1.26B 107M 105M 4.52B |
| Net Debt | - | - |
Employees
117
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/03/26 | 4.890 $ | -6.32% | 1,781,670 |
| 10/03/26 | 5.220 $ | +2.15% | 1,947,857 |
| 09/03/26 | 5.110 $ | +0.99% | 2,794,872 |
| 06/03/26 | 5.060 $ | -0.78% | 2,432,348 |
| 05/03/26 | 5.100 $ | +3.24% | 4,492,503 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.890USD
Average target price
13.60USD
Spread / Average Target
+178.12%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NAGE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















